Diabetology & Metabolic Syndrome
Scope & Guideline
Shaping the future of diabetes care and management.
Introduction
Aims and Scopes
- Diabetes Management and Treatment Strategies:
Research on various treatment modalities for diabetes, including pharmacological interventions (like GLP-1 receptor agonists and SGLT2 inhibitors), dietary approaches, and lifestyle modifications aimed at improving glycemic control and managing diabetes-related complications. - Cardiometabolic Health:
Studies investigating the interrelations between diabetes and cardiovascular diseases, metabolic syndrome, and other comorbidities, focusing on risk factors, outcomes, and management strategies. - Pathophysiology of Diabetes Complications:
Research into the underlying mechanisms of diabetes-related complications, including nephropathy, retinopathy, neuropathy, and cardiovascular disease, often utilizing molecular, genetic, and epigenetic analyses. - Innovative Diagnostic and Monitoring Technologies:
Advancements in diabetes monitoring technologies such as continuous glucose monitoring systems, machine learning applications for diabetes risk prediction, and novel biomarkers for early detection of diabetes-related complications. - Public Health and Epidemiology:
Investigations into the prevalence, risk factors, and socio-economic impacts of diabetes and metabolic syndrome at population levels, aiming to inform public health policies and interventions. - Patient-Centered Care and Education:
Research focusing on the psychosocial aspects of diabetes, including patient education, self-management strategies, and the impact of mental health on diabetes outcomes.
Trending and Emerging
- Molecular Mechanisms and Biomarkers:
There is a growing emphasis on understanding the molecular mechanisms underlying diabetes and its complications, including the identification of novel biomarkers for early detection and monitoring of diabetes-related conditions. - Impact of Gut Microbiota:
Research exploring the relationship between gut microbiota and diabetes has gained traction, focusing on how gut health influences metabolic processes, insulin resistance, and overall diabetes management. - Psychosocial and Behavioral Aspects of Diabetes Management:
Increasing attention is being paid to the psychosocial dimensions of diabetes, including the effects of mental health, stress, and social support on diabetes outcomes, as well as the role of patient education and self-management. - Artificial Intelligence and Digital Health Technologies:
The integration of artificial intelligence and digital health technologies in diabetes management is an emerging trend, with studies focusing on predictive modeling, telemedicine, and mobile health applications to enhance patient care. - Diabetes in Special Populations:
Research focusing on diabetes management and outcomes in specific populations, such as children, adolescents, pregnant women, and ethnic minorities, is gaining importance, reflecting the need for tailored approaches in diabetes care.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for diabetes management, such as specific diets or food groups, has seen a decline. This shift is likely due to a growing emphasis on personalized nutrition and the role of overall dietary patterns. - Single-Agent Pharmacotherapy Studies:
The focus on studies investigating single-agent pharmacotherapy for diabetes management has waned. There is now a greater interest in combination therapies and multi-faceted approaches that address the complexity of diabetes. - Basic Science Studies with Limited Clinical Relevance:
While basic science research remains important, studies that do not translate findings into clinical or practical applications are less prevalent. The journal is increasingly prioritizing research that has direct implications for patient care and outcomes. - Generalized Population Studies:
Research that broadly examines diabetes prevalence without nuanced analysis of specific populations or subgroups is decreasing. There is a trend towards more targeted studies that consider ethnic, cultural, and socio-economic factors influencing diabetes.
Similar Journals
Endocrinology Diabetes and Metabolism Case Reports
Innovating Clinical Practices Through Case StudiesEndocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.
HORMONE AND METABOLIC RESEARCH
Unraveling the Complexities of Hormonal InfluenceHORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.
Cardiovascular Diabetology
Empowering Research to Transform Cardiovascular and Diabetes OutcomesCardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.
ENDOCRINE JOURNAL
Connecting professionals through pioneering endocrinology research.ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.
Diabetology
Advancing knowledge in diabetes and metabolism.Diabetology, published by MDPI, is an esteemed Open Access journal dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. Launched in 2020, this journal has quickly established itself, achieving a Category Quartile ranking of Q3 in Endocrinology, Diabetes and Metabolism and Q2 in Internal Medicine as of 2023. With a commitment to disseminating high-quality research, Diabetology provides an important platform for scientists, healthcare professionals, and students to contribute to the growing body of knowledge regarding diabetes and related conditions. Operating from its headquarters in Basel, Switzerland, the journal embraces an open access model, ensuring that research is accessible worldwide, fostering collaboration and innovation in this critical area of health. As the global diabetic epidemic continues to evolve, Diabetology plays a vital role in informing and educating stakeholders through rigorous peer-reviewed articles while boosting its visibility with impressive Scopus rankings. This journal is not only a resource for current data and findings but also a hub for groundbreaking studies that strive to improve patient outcomes and inform public health policies.
DIABETES & METABOLISM
Fostering Excellence in Diabetes Research and EducationDIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.
DIABETES CARE
Leading the way in diabetes research excellence.DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.
Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
Advancing knowledge in endocrinology and metabolism.Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.
DIABETES OBESITY & METABOLISM
Connecting researchers to enhance patient care in endocrinology.DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.
Turkish Journal of Endocrinology and Metabolism
Exploring New Frontiers in Endocrinology and Metabolic DisordersThe Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.